Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Otenabant

Generic Name: Otenabant

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₂₅Cl_₂N_₇O

CAS Number: 686344-29-6

Unique Ingredient Identifier: J8211Y53EF

Overview

Otenabant has been investigated for the treatment of Obesity.

Background

Otenabant has been investigated for the treatment of Obesity.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

The Role of Endocannabinoids in Insulin Production and Action

Phase 1

Completed

Posted: 2012/01/25

Sponsor:

National Institute o...

ID:NCT01517100

Effect of Diltiazem Administration on CP-945,598 Pharmacokinetics

Phase 1

Completed

Posted: 2008/03/27

Sponsor:Pfizer

ID:NCT00645463

Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

Phase 1

Completed

Posted: 2008/03/27

Sponsor:Pfizer

ID:NCT00645021

Study Examing The Effect Of Omeprazole On Safety, Tolerability And How The Body Processes An Experimental Drug

Phase 1

Completed

Posted: 2008/03/27

Sponsor:Pfizer

ID:NCT00644839

Study Examing The Effect of Grapefruit Juice On The Blood And Urine Samples of Study Drug And Its By Product And Safety

Phase 1

Completed

Posted: 2008/03/27

Sponsor:Pfizer

ID:NCT00645216

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy